ClinConnect ClinConnect Logo
Search / Trial NCT06891976

Effect of Acupressure Versus Kinesotape on Low Back Pain in Women Who Use Intrauterine Device

Launched by CAIRO UNIVERSITY · Mar 18, 2025

Trial Information

Current as of April 29, 2025

Not yet recruiting

Keywords

ClinConnect Summary

This clinical trial is looking to compare two different treatments for low back pain in women who use an intrauterine device (IUD) for birth control. The treatments being studied are acupressure, which is a technique that applies pressure to specific points on the body, and kinesiotape, which is a stretchy tape applied to the skin to support muscles and joints. The goal is to see which method is more effective in relieving low back pain that may occur after the insertion of an IUD.

To be eligible for the study, participants must be women aged 25 to 30 who are experiencing significant low back pain (rated above 4 on a pain scale) after getting their IUD within the last year. They should also have a body mass index (BMI) under 30 and be in good health. Women with certain conditions, like pelvic infections, unexplained vaginal bleeding, or specific medical issues causing back pain, will not be included in the study. If you decide to participate, you can expect to receive one of the two treatments and contribute to understanding how to better manage low back pain related to IUD use.

Gender

FEMALE

Eligibility criteria

  • Inclusion Criteria:
  • Females suffer from low back pain resulted from intrauterine device use, they are referred by the gynecologist.
  • Their pain level will be\> 4 on the visual analogue scale (VAS).
  • Their ages will be ranged from 25 to 30 years.
  • Their BMI will be less than 30 kg /m2
  • Women diagnosed with low back pain upon recent insertion of intrauterine device (within a year)
  • All patients will be clinically and medically stable when attending the study.
  • Exclusion Criteria:
  • Current pelvic infection, usually pelvic inflammatory disease (PID), mucopurulent cervicitis with a suspected STI, pelvic tuberculosis, septic abortion, or puerperal endometritis or sepsis within the past 3 months
  • Unexplained vaginal bleeding
  • Patients having skin disease or known allergy to kinesio tape
  • Having LBP due to trauma, spondylolisthesis, ankylosing spondylitis, fibromyalgia, diabetes mellitus or due to any gynecological problems that may cause LBP like polycystic ovarian syndrome (PCO), endometriosis, adenomyosis, cervicitis, uterine prolapse etc.

About Cairo University

Cairo University, a premier institution in Egypt, is dedicated to advancing medical research and education through innovative clinical trials. With a strong emphasis on improving healthcare outcomes, the university collaborates with various stakeholders to conduct rigorous scientific studies that address critical health challenges. Leveraging its extensive resources and expert faculty, Cairo University aims to contribute valuable insights to the medical community and enhance patient care both locally and globally. Through its commitment to ethical research practices and excellence, the university plays a pivotal role in shaping the future of healthcare in the region.

Locations

Giza, , Egypt

Patients applied

0 patients applied

Trial Officials

Hala Mohamed Hanfy Omaera, PhD

Study Chair

Professor, Cairo university

Hossam El Deen Kamel, PhD

Study Director

Professor, Al-Azhar university

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported